Professor Jeeyun Lee, MD, PhD

Professor Jeeyun Lee, MD, PhD

Department of Hematology and Oncology
Samsung Medical Center
SungKyunKwan University School of Medicine
Seoul, Korea

Related Videos

Does FoundationOne's comprehensive genomic profiling have validation studies confirming accuracy across multiple alterations in a peer-reviewed journal? Video

Does FoundationOne's comprehensive genomic profiling have validation studies confirming accuracy across multiple alterations in a peer-reviewed journal?

Does FoundationOne’s comprehensive genomic profiling have validation studies confirming accuracy across multiple alterations in a peer-reviewed journal? Please discuss. Do you know of any other genomic profiling services that are clinically ...

What are the findings of exploratory studies in which FoundationOne NGS genomic profiling targeting 145 "cancer-relevant" genes is applied to colorectal cancer and gastric cancer? Video

What are the findings of exploratory studies in which FoundationOne NGS genomic profiling targeting 145 "cancer-relevant" genes is applied to colorectal cancer and gastric cancer?

What are the published top-line findings of exploratory studies in which FoundationOne NGS genomic profiling targeting 145 “cancer-relevant”genes is applied to colorectal cancer and gastric cancer?

Why are current genomic testing models based on targeted sequencing ("Hot Spot") unsustainable and more limited than comprehensive genomic profiling (CGP) developed by FoundationOne? Video

Why are current genomic testing models based on targeted sequencing ("Hot Spot") unsustainable and more limited than comprehensive genomic profiling (CGP) developed by FoundationOne?

Why are current genomic testing models based on targeted sequencing (“Hot Spot”) unsustainable and more limited than comprehensive genomic profiling (CGP) developed by FoundationOne?

How does massively parallel DNA sequencing overcome considerations regarding pathological tumor specimens? Video

How does massively parallel DNA sequencing overcome considerations regarding pathological tumor specimens?

How does massively parallel (or ‘next-generation’) DNA sequencing overcome the following practical considerations regarding pathological tumor specimens? (1) Using FFPE specimens, a process that may damage DNA? (2) Accommodating limited ...

Which critical and actionable tumor-specific molecular targets are likely to be missed by Hot Spot profiling as opposed to CGP and why is CGP advantageous in most cancer patients? Video

Which critical and actionable tumor-specific molecular targets are likely to be missed by Hot Spot profiling as opposed to CGP and why is CGP advantageous in most cancer patients?

Since Hot Spot profiling is inadequate for detecting copy number alterations and rearrangements, which critical and actionable tumor-specific molecular targets are likely to be missed by Hot Spot profiling as opposed to CGP and why is ...

Why are current genomic testing models based on targeted sequencing ("Hot Spot") unsustainable and less effective than comprehensive genomic profiling (GGP) developed by FoundationOne? Video

Why are current genomic testing models based on targeted sequencing ("Hot Spot") unsustainable and less effective than comprehensive genomic profiling (GGP) developed by FoundationOne?

Why are current genomic testing models based on targeted sequencing (“Hot Spot”) unsustainable and less effective than comprehensive genomic profiling (GGP) developed by FoundationOne?

What is the evidence that a systematic and comprehensive NGS-generated profiling of actionable alterations in genes associated with solid tumors should or can inform therapeutic decision-making? Video

What is the evidence that a systematic and comprehensive NGS-generated profiling of actionable alterations in genes associated with solid tumors should or can inform therapeutic decision-making?

What is the evidence supporting the observation that a systematic and comprehensive NGS-generated profiling of actionable alterations in genes associated with solid tumors should or can inform therapeutic decision-making?